Accéder au contenu
Merck
Toutes les photos(1)

Documents

Y0001326

Imidazole

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

1,3-Diaza-2,4-cyclopentadiène, Glyoxaline

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C3H4N2
Numéro CAS:
288-32-4
Poids moléculaire :
68.08
Numéro Beilstein :
103853
Numéro MDL:
MFCD00005183
Code UNSPSC :
41116107
ID de substance PubChem :
329831367
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Pression de vapeur

<1 mmHg ( 20 °C)

Famille d'API

ondansetron

Fabricant/nom de marque

EDQM

pKa (25 °C)

6.95

Point d'ébullition

256 °C (lit.)

Pf

88-91 °C (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

c1c[nH]cn1

InChI

1S/C3H4N2/c1-2-5-3-4-1/h1-3H,(H,4,5)

Clé InChI

RAXXELZNTBOGNW-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Excellent pour les tampons compris dans la plage de pH 6,2-7,8

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

PHR1141

Ondansetron Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

1478618

Ondansetron Related Compound C, United States Pharmacopeia (USP) Reference Standard

1478593

Ondansetron Related Compound A, United States Pharmacopeia (USP) Reference Standard

1478629

Ondansetron Related Compound D, United States Pharmacopeia (USP) Reference Standard

1478582

Ondansetron hydrochloride, United States Pharmacopeia (USP) Reference Standard

1478630

Ondansetron Resolution Mixture, United States Pharmacopeia (USP) Reference Standard

PHR1181

2-Methylimidazole (Ondansetron Impurity F), Pharmaceutical Secondary Standard; Certified Reference Material

Y0000195

Ondansetron impurity D, European Pharmacopoeia (EP) Reference Standard

Y0000196

Ondansetron for TLC system suitability, European Pharmacopoeia (EP) Reference Standard

Y0000197

Ondansetron for LC system suitability, European Pharmacopoeia (EP) Reference Standard

Y0000218

Ondansetron hydrochloride dihydrate, European Pharmacopoeia (EP) Reference Standard

Y0001320

Ondansetron impurity F, European Pharmacopoeia (EP) Reference Standard

Y0001345

Ondansetron impurity A, European Pharmacopoeia (EP) Reference Standard

Y0001346

Ondansetron impurity G, European Pharmacopoeia (EP) Reference Standard

1478571

Ondansetron, United States Pharmacopeia (USP) Reference Standard

BP808

Ondansetron hydrochloride dihydrate, British Pharmacopoeia (BP) Reference Standard

BP806

Ondansetron impurity standard, British Pharmacopoeia (BP) Reference Standard

PHR2224

Ondansetron Related Compound C, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2223

Ondansetron Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2221

Ondansetron Related Compound D, Pharmaceutical Secondary Standard; Certified Reference Material

Pictogrammes

Health hazardCorrosionExclamation mark
GHS08,GHS05,GHS07

Mention d'avertissement

Danger

Mentions de danger

H302,H314,H360D

Classification des risques

Acute Tox. 4 Oral - Eye Dam. 1 - Repr. 1B - Skin Corr. 1C

Code de la classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

293.0 °F - closed cup

Point d'éclair (°C)

145 °C - closed cup

Choose from one of the most recent versions:

Certificats d'analyse (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Joy Rathjen et al.
Reproduction, fertility, and development, 26(5), 703-716 (2013-06-14)
Human embryonic stem (ES) cells have been proposed as a renewable source of pluripotent cells that can be differentiated into various cell types for use in research, drug discovery and in the emerging area of regenerative medicine. Exploitation of this
Joel E Schmidt et al.
Angewandte Chemie (International ed. in English), 53(32), 8372-8374 (2014-06-26)
Crystalline molecular sieves are used in numerous applications, where the properties exploited for each technology are the direct consequence of structural features. New materials are typically discovered by trial and error, and in many cases, organic structure-directing agents (OSDAs) are
Daan de Gouw et al.
PloS one, 9(8), e105011-e105011 (2014-08-19)
Pertussis is a highly infectious respiratory disease of humans caused by the bacterium Bordetella pertussis. Despite high vaccination coverage, pertussis has re-emerged globally. Causes for the re-emergence of pertussis include limited duration of protection conferred by acellular pertussis vaccines (aP)
Alexandar L Hansen et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(17), E1705-E1712 (2014-04-16)
The histidine imidazole side chain plays a critical role in protein function and stability. Its importance for catalysis is underscored by the fact that histidines are localized to active sites in ∼ 50% of all enzymes. NMR spectroscopy has become
E Rosalie Witjas-Paalberends et al.
The Journal of physiology, 592(15), 3257-3272 (2014-06-15)
The first mutation associated with hypertrophic cardiomyopathy (HCM) is the R403Q mutation in the gene encoding β-myosin heavy chain (β-MyHC). R403Q locates in the globular head of myosin (S1), responsible for interaction with actin, and thus motor function of myosin.
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique